EIB to support Ryvu Therapeutics' discovery, research and development of new cancer treatments with €22 million

EU Cybersecurity: Commission proposes a Joint Cyber Unit to step up response to large-scale security incidents

European Commission Press release Brussels, 17 Aug 2022 The European Investment Bank (EIB) is providing €22 million (above 100 million polish zlotys) in financing to Ryvu Therapeutics, a Polish clinical-stage drug discovery and development company focusing on novel small molecule therapies that address unmet medical needs in oncology.

by : European Commission on 2022-08-16 22:00:00

Source link

#EIB #support #Ryvu #Therapeutics039 #discovery #research #development #cancer #treatments #million

Capital Media

Read Previous

Rate for : JAPAN

Read Next

Supreme Court clears Central Bank of Sri Lanka over Greek investment

%d bloggers like this: